Aurobindo Pharma Ltd. (NSE:AUROPHARMA) is a global pharmaceutical company headquartered in India. The company produces and sells a wide range of generic
Categories
pharmaceuticals
Earnings | AstraZeneca Pharma India Ltd. (NSE:ASTRAZEN): Q3FY23 Results Out; Total Income rise 25% YoY
AstraZeneca Pharma India Ltd. (NSE:ASTRAZEN) is a leading biopharmaceutical company that operates in India. The company manufactures and markets prescription drugs for
Earnings Summary Of FDC Limited For Q3 FY23
FDC Limited (NSE: FDC) is a leading Indian pharmaceutical company that specializes in the manufacturing and marketing of a wide range of
Gufic Biosciences Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Gufic Biosciences Limited (GUFICBIO) Q3 FY23 Earnings Concall Q&A Highlights: [00:11:06] Gunit Singh from CCIPL enquired about the driver
Earnings | Alkem Laboratories Ltd.(NSE:ALKEM): Q3FY23 Results Out; Total Income rise 15% YoY
Alkem Laboratories Ltd.(NSE:ALKEM) is a pharmaceutical company based in India that specializes in the manufacturing and marketing of generic and branded drugs,
Earnings Summary Of GlaxoSmithKline Pharmaceuticals Limited For Q3 FY23
GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO) is a leading pharmaceutical company in India that develops, manufactures, and markets a range of pharmaceutical products
Earnings|Aarti Drugs Ltd (NSE:AARTIDRUGS): Q3FY23 Results Out; Total Income rise 4% YoY
Aarti Drugs Ltd (NSE:AARTIDRUGS) is a leading Indian pharmaceutical company that specializes in the manufacture and export of bulk drugs. The company
Earnings|Abbott India Ltd (NSE:ABBOTTINDIA) : Q3FY23 Results Out; Total Income rise 10% YoY
Abbott India Ltd (NSE:ABBOTTINDIA) is a subsidiary of the global healthcare company, Abbott Laboratories. It was established in 1944 and is headquartered
SMS Pharmaceuticals Ltd (SMSPHARMA) Q3 FY23 Earnings Concall Transcript
SMS Pharmaceuticals Ltd (NSE:SMSPHARMA) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vamsi Krishna Potluri -- Executive Director Unidentified Speaker -- Analysts: Viraj
Earnings Summary Of Hikal Limited For Q3 FY23
Hikal Limited (NSE: HIKAL) is a leading Indian life sciences company with a global presence. The company specializes in developing and manufacturing
IPCA Laboratories Ltd (IPCALAB) Q3 FY23 Earnings Concall Transcript
IPCA Laboratories Ltd (NSE:IPCALAB) Q3 FY23 Earnings Concall dated Feb. 16, 2023. Corporate Participants: Ajit Kumar Jain -- Joint Managing Director Harish Kamath -- Corporate Counsel
Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT): Q3FY23 Results Out; Total Income rise 15% YoY
Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT) is a pharmaceutical company based in India. It is engaged in the development, manufacture, and marketing
Shilpa Medicare Ltd (SHILPAMED) Q3 FY23 Earnings Concall Transcript
Shilpa Medicare Ltd (NSE: SHILPAMED) Q3 FY23 Earnings Concall dated Feb. 15, 2023 Corporate Participants: Vishnukanth Bhutada -- Managing Director Alpesh Dalal -- Chief Financial Officer
Biocon Limited (BIOCON) Q3 FY23 Earnings Concall Transcript
Biocon Limited (NSE:BIOCON) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Saurabh Paliwal -- Head - Investor Relations Kiran Mazumdar Shaw -- Biocon Ltd.
Marksans Pharma Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Marksans Pharma Limited (MARKSANS) Q3 FY23 Earnings Concall Q&A Highlights: [00:08:54] Riddhesh Gandhi from Discovery Capital asked why there
Earnings Summary Of Granules India Limited For Q3 FY23
Granules India Limited (NSE: GRANULES) is a pharmaceutical manufacturing company based in Hyderabad, India. The company was founded in 1984 and has
Marksans Pharma Limited (MARKSANS) Q3 FY23 Earnings Concall Transcript
Marksans Pharma Limited (NSE:MARKSANS) Q3 FY23 Earnings Concall dated Feb. 14, 2023. Corporate Participants: Mark Saldanha -- Managing Director and Chief Executive Officer Jitendra
Biocon ltd.(NSE: BIOCON) Ltd. : Q3 FY23 Results Out; Total Income rise 35% YoY
Biocon Limited (NSE:BIOCON) is an Indian multinational biopharmaceutical company based in Bangalore, India. The company was founded in 1978 by Kiran Mazumdar-Shaw
Brooks Laboratories Ltd.(NSE: BROOKS) Ltd. : Q3 FY23 Results Out; Total Income fell 20% YoY
Brooks Laboratories Limited (NSE: BROOKS) is a pharmaceutical contract research and manufacturing services company based in India. It offers a range of
Themis Medicare Ltd (THEMISMED) Q3 FY23 Earnings Concall Transcript
Themis Medicare Ltd (NSE:THEMISMED) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Sachin D. Patel -- Managing Director and Chief Executive Officer
Ipca Laboratories Limited Q3 FY23; Revenue Increased To ₹1,546 Crore
Ipca Laboratories Limited (NSE: IPCALAB) reported Revenue from Operations for Q3 FY23 of ₹1,546 Crore up from ₹1,430.47 Crore year on year,